1. Bioavailability and bioequivalence studies are essential to ensure uniform quality, efficacy, and safety of pharmaceutical products containing the same active ingredient marketed by different companies.
2. Pharmacokinetic studies measure the rate and extent of absorption of a drug from its dosage form and subsequent availability in systemic circulation. They involve measuring drug concentrations in biological fluids over time to establish equivalence between formulations.
3. Key factors in study design include subject selection criteria, sample size calculation, exclusion criteria, and genetic phenotyping to account for population diversity when assessing bioequivalence of drug products.